| Dr Eugene Henschel Jr, MD | |
|
9205 Sw Barnes Rd, Portland, OR 97225-6603 | |
| (503) 215-4323 | |
| (503) 215-0297 |
| Full Name | Dr Eugene Henschel Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology - Clinical Pathology/laboratory Medicine |
| Location | 9205 Sw Barnes Rd, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619196003 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0105X | Pathology - Clinical Pathology/laboratory Medicine | MD13597 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eugene Henschel Jr, MD Po Box 3396, Portland, OR 97208-3396 Ph: (503) 215-4323 | Dr Eugene Henschel Jr, MD 9205 Sw Barnes Rd, Portland, OR 97225-6603 Ph: (503) 215-4323 |
News Archive
The Hemophilia Federation of America (HFA) expresses its concern regarding the ongoing labor issues involving the Teamsters Local 929 and the American Red Cross of Pennsylvania /New Jersey.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced a new contractual agreement with Generation Health, Inc. (GH). This agreement makes Clarient a preferred genetic testing lab for GH, thereby ensuring reimbursement of diagnostic tests done for GH's nationwide network of payor clients and expanding Clarient's potential market. GH is a genetic benefit management company partially-owned by CVS Caremark, the nation's largest pharmacy healthcare provider.
Each week, KHN reporter Alvin Tran compiles a selection of recently released health policy studies and briefs.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced today that the US Food and Drug Administration (FDA) has notified the company of the confirmed scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application (NDA). Lorcaserin, which Arena discovered and has developed for weight management, is intended for obese patients as well as overweight patients who have at least one weight-related co-morbid condition.
› Verified 9 days ago
Dr. Kevin P Sargeant, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8276 Fax: 503-494-2025 | |
Mary Jo Drew, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 3131 N. Vancouver Ave., American Red Cross Pnw Regional Blood Services, Portland, OR 97227 Phone: 503-528-5920 | |
Dr. Judith Ann Ray, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1015 Nw 22nd Ave, Portland, OR 97210 Phone: 503-413-8259 Fax: 503-413-6267 | |
Matthew Carstens Frank, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 303-859-4275 | |
Sarah Walter, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1015 Nw 22nd Ave, Dept Of Pathology, Portland, OR 97210 Phone: 503-237-0507 | |
Matthew Evans, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1015 Nw 22nd Ave, Portland, OR 97210 Phone: 800-649-8730 | |
Jacob Tyler Abel, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-6096 |